Hot Defensive Companies For 2015

MoneyShow’s Jim Jubak analyzes the current market action and wonders whether the prevailing sentiment can last until the earnings season kicks in.

For the week ahead, well maybe the next two or three weeks ahead, we’re in a kind of race to see what ends first, whether it’s the market’s complacency about the government shutdown and the debt ceiling battle, or whether it’s the government shutdown and the debt ceiling battle itself.

Right now it looks like the market is pretty much assuming that this is going to be over in like a week, it’s not going to have a whole lot of effect. It’s not going to lead into some kind of bigger battle over the debt ceiling. In fact, it may mean that the debt ceiling battle itself will be resolved fairly easily, but you’ve got things like on October 2, you had the ADP research numbers on jobs. Now, there won’t be a government report this week, the government is shutdown, so the September jobs numbers, which were supposed to come out on Friday, October 4, won’t come out, so this is the only jobs number we have for September, probably for a while.

Hot Defensive Companies For 2015: Dynavax Technologies Corporation(DVAX)

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious diseases. The company’s lead product candidate includes HEPLISAV, a Phase 3 investigational adult hepatitis B vaccine designed to provide protection with fewer doses than current licensed vaccines. It also develops Universal Flu vaccine, a Phase 1b clinical trial vaccine for influenza prevention; SD-101, a Phase Ib clinical trial hepatitis C therapy; DV-601, a Phase Ib clinical trial hepatitis B therapy; AZD1419, a preclinical asthma therapy; and DV1179, a Phase 1 trial autoimmune and inflammatory disease therapy. Dynavax Technologies Corporation has strategic alliance with GlaxoSmithKline plc to discover, develop, and commercialize DV1179 and other endosomal toll-like receptor inhibitors for diseases, such as lupus, psoriasis, and rheumatoid arthritis; and develop a TLR8 inhibitor for the treatment of multiple autoimmune and i nflammatory diseases, as well as has research and license agreement with AstraZeneca to discover and develop TLR9 agonist-based therapies for the treatment of asthma and chronic obstructive pulmonary disease. The company was founded in 1996 and is based in Berkeley, California.

Advisors’ Opinion:

  • [By Roberto Pedone]

    Another under-$10 bio therapeutic player that’s starting to trend within range of triggering a major breakout trade is Dynavax Technologies (DVAX), which discovers and develops novel products to prevent and treat infectious and inflammatory diseases. This stock has been hit hard by the sellers so far in 2013, with shares off sharply by 55%.

    If you take a look at the chart for Dynavax Technologies, you’ll notice that this stock has been trending inside of a big range for the last three months and change, with shares moving between $1.10 on the downside and $1.46 on the upside. This large consolidation pattern for DVAX could mean that this stock is under accumulation by the bulls, since the bears have been unable to push the stock out of this range and take it to new lows. Shares of DVAX are now starting to spike back above its 50-day moving average of $1.25 a share with decent upside volume. Volume so far on Thursday has already registered 1.6 million shares versus its three-month average action or 1.81 million shares. This move is starting to push DVAX within range of triggering a major breakout trade.

    Market players should now look for long-biased trades in DVAX if it manages to break out above some key overhead resistance levels at $1.29 to $1.32 a share, and then once it takes out more resistance at $1.46 to $1.50 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 1.81 million shares. If that breakout hits soon, then DVAX will set up to re-test or possibly take out its next major overhead resistance level at $1.70 a share. Any high-volume move above $1.70 a share will then give DVAX a chance to re-fill some of its previous gap down zone from June that started at $2.60 a share.

    Traders can look to buy DVAX off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support at $1.10 a sha

  • [By Rich Smith]

    Berkeley, Calif.-based Dynavax Technologies (NASDAQ: DVAX  ) has a new chief executive officer.

    On Tuesday, the vaccine manufacturer announced that current CEO Dr. Dino Dina will retire on May 1, and will be succeeded by Eddie Gray, who comes from GlaxoSmithKline, where the doctor had served as president of Pharmaceuticals, Europe, since 2008.

  • [By Keith Speights]

    Of course, developing a product for a market with great opportunity doesn’t guarantee success for your investment strategy. An estimated 1 million people die each year from complications related to hepatitis B. Dynavax (NASDAQ: DVAX  ) developed a hep-B vaccine, Heplisav, that showed tremendous promise. However, safety concerns derailed approval for the drug. While Heplisav might still reach the market, Dynavax’s experience highlights the risks even in a market with solid potential.

  • [By Selena Maranjian]

    Finally, Westfield’s biggest closed positions included Ralcorp and Vertex Pharmaceuticals. Other closed positions of interest include Dynavax (NASDAQ: DVAX  ) and JDS Uniphase (NASDAQ: JDSU  ) . Dynavax shares fell sharply upon an FDA rejection of its hepatitis B vaccine Heplisav. The FDA left open the possibility of a more limited approval, but Dynavax now has more work to do, and it’s burning cash while its revenue has been shrinking. Fortunately, it does seem to have have ample cash to keep it afloat for a few years. Investors are right to worry about share dilution, too. Dynavax has partnered with GlaxoSmithKline on Heplisav, and its new CEO hails from GlaxoSmithKline as well.

Hot Defensive Companies For 2015: First Trust NASDAQ Clean Edge Green Energy Index Fund (QCLN)

First Trust NASDAQ Clean Edge US (ETF) seeks investment results that correspond to the price and yield of an equity index of the NASDAQ Clean Edge U.S. Liquid Series Index. It is a market capitalization weighted index designed to track the performance of clean energy companies that are publicly traded in the United States and includes companies engaged in manufacturing, development, distribution and installation of emerging clean-energy technologies, including solar photovoltaics, biofuels and advanced batteries.

The NASDAQ Clean Edge U.S. Liquid Series Index is a modified market cap weighted index in which larger companies receive a larger index weighting. First Trust Advisors L.P. is the adviser of the fund.

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    The news was predictably good for a pair of ETFs that should be known as “Tesla ETFs.” The Market Vectors Global Alternatve Energy ETF (NYSE: GEX) and the First Trust NASDAQ Clean Edge Green Energy Index Fund (NASDAQ: QCLN) both traded higher on a down day for U.S. stocks, rising to within pennies of their previous 52-week highs.

Hot Defensive Companies For 2015: Oshkosh Truck Corporation(OSK)

Oshkosh Corporation designs, manufactures, and markets a range of specialty vehicles, and vehicle bodies worldwide. Its Defense segment manufactures severe-duty, heavy, and medium-payload tactical trucks for the Department of Defense, including hauling tanks, missile systems, ammunition, fuel, and troops and cargo for combat units. The company?s Access Equipment segment offers aerial work platforms and telehandlers used in a range of construction, agricultural, industrial, institutional, and general maintenance applications. This segment also manufactures towing and recovery equipment and related parts; and leases equipments for short-term to rental companies. The company?s Fire and Emergency segment provides custom and commercial fire apparatus, and emergency vehicles, including pumpers, aerial and ladder trucks, tankers, rescue vehicles, wildland rough terrain response vehicles, mobile command and control centers, bomb squad vehicles, hazardous materials control vehicl e s, and other emergency response vehicles. This segment also offers snow removal vehicles in airports; custom ambulances for private and public transporters, and fire departments; mobile medical trailers for medical centers and service providers; mobile command and control centers and simulation units; and vehicles for broadcasters, TV stations, broadcast production, and radio stations. Oshkosh Corporation?s Commercial segment manufactures refuse collection vehicles for the waste services industry; front and rear discharge concrete mixers, and portable and stationary concrete batch plants for the concrete ready-mix industry; and field service vehicles and truck-mounted cranes for the construction, equipment dealer, building supply, utility, tire service, and mining industries. The company was formerly known as Oshkosh Truck Corporation and changed its name to Oshkosh Corporation in February 2008. Oshkosh Corporation was founded in 1917 and is based in Oshkosh, Wisconsin.

Advisors’ Opinion:

  • [By Rich Smith]

    Better protection for soldiers, too
    A smaller contract went to Oshkosh Corp. (NYSE: OSK  ) to bolster protection for troops on the ground. Valued at $45 million, the award will fund repairs and upgrades on 800 of the company’s Mine-Resistant, Ambush-Protected All-Terrain Vehicles, dubbed “M-ATV,” and used primarily to transport troops and supplies in Afghanistan. Work performed under this contract will continue through the end of next year — which suggests U.S. troops will be present in Afghanistan at least that long as well.

  • [By Ben Levisohn]

    Shares of Navistar have dropped 4.1% to $31.89 at 2:02 p.m. today, while Oshkosh (OSK) has fallen 0.2% to $57.76 and Cummins (CMI) has gained 1.2% to $144.13.

  • [By Jake L’Ecuyer]

    Shares of Oshkosh (NYSE: OSK) got a boost, shooting up 7.96 percent to $55.55 after the companyposted upbeat fiscal first-quarter earnings and lifted its full-year forecast.

Hot Defensive Companies For 2015: Liquidmetal Technologies Inc (LQMT)

Liquidmetal Technologies, Inc. (Liquidmetal Technologies), incorporated in 1987, is materials technology company that develops and commercializes products made from amorphous alloys. The Company’s Liquidmetal family of alloys consists of a variety of bulk alloys and composites that utilize the advantages offered by amorphous alloy technology. The Company designs develop and sell products and components from bulk amorphous alloys to customers in various industries. The Company also partners with third-party manufacturers and licensees to develop and commercialize Liquidmetal alloy products. The Company focused to commercializes its Liquidmetal alloys on three identified product areas, such as Components for Non-Consumer Electronic Products, Sporting Goods and Leisure Products and Medical Devices. On December 1, 2011, the Company entered into a Share Purchase Agreement with LMTK Holdings, Inc. (LMTK Holdings) to sell its former Korean subsidiary and manufacturing facility, L iquidmetal Technologies Korea (LMTK). Under the Share Purchase Agreement, the Company sold all of LMTK’s shares of common stock to LMTK Holdings.

The Company designs, develops and produces components for non-consumer electronic devices utilizing its bulk Liquidmetal alloys. The product categories in the non-consumer electronics field include, but are not limited to, parts for high end printers, commercial imaging devices, aerospace components, medical devices and industrial machines. The Company is also developing a variety of applications for Liquidmetal alloys in the sporting goods and leisure products area.

The Company develops a variety of applications for Liquidmetal alloys in the sporting goods and leisure products area. In the sporting goods industry the Company focuses on products that meet its design criteria. The Company has produced prototype rings made from an amorphous Liquidmetal platinum alloy that is harder, in the leisure product s category. The Company emphasis on surgical instrument appl! ications for Liquidmetal alloys. These include, but are not limited to, specialized blades, orthopedic instruments utilized for implant surgery procedures, dental devices and general surgery devices

The Company is engaged in product development efforts relating to various medical devices that could be made from bulk Liquidmetal alloys. The properties of bulk Liquidmetal alloys provide a combination of performance that makes them a replacement to incumbent materials, such as stainless steel and titanium.

Advisors’ Opinion:

  • [By James E. Brumley]

    Looking for a couple of near-term trades that have a decent shot at rallying even if the broad market feels like it might pull back? Then take a look at Liquidmetal Technologies Inc. (OTCBB:LQMT) and NanoTech Entertainment, Inc. (OTCMKTS:NTEK). Although both LQMT and NTEK will be dismissed by some traders simply because they’re OTC-listed stocks, for those traders willing to look past the exchange and appreciate the opportunity, the risk-versus-reward ratio is actually quite compelling.

  • [By James E. Brumley]

    While it may be melodramatic to say my following of Liquidmetal Technologies Inc. (OTCBB:LQMT) has been something of a ‘saga’, it wouldn’t be unfair to say it’s one of those small cap stocks that’s had its fair share of twists and turns. Yours truly turned explicitly bullish on LQMT back on November 22nd, after the stock broke above a key falling resistance lines. Then, on January 14th, I made a point of saying the rally had run its course, and it was time to lock in your 47% gain on Liquidmetal Technologies and walk away… at least for a while.

  • [By James E. Brumley]

    Well, I hate to be the one to say I told you so, but, I told you so. Back on November 22nd I told you the gain from Liquidmetal Technologies Inc. (OTCBB:LQMT) was no ordinary gain. It was a catalyst for a much bigger bullish move. See, with that day’s advance, LQMT hopped above a nagging resistance line. The end result was a stock that was not only proverbially free to move about the cabin, but a stock that had proven it had already established some upward momentum. Sure enough, Liquidmetal Technologies shares are up 47% since then. You’re welcome.

  • [By James E. Brumley]

    The 7% pop we’re seeing from Liquidmetal Technologies Inc. (OTCBB:LQMT) today is impressive, but we’ve all seen big – and even bigger – gains from stocks before. What makes this one any different than the hundred of other stocks that dole out one-day wonder gains on any given trading day? Well, as it turns out, there actually is something significantly different with the way LQMT is flying high today.

Hot Defensive Companies For 2015: Eaton Vance Tax-Managed Diversified Equity Income Fund (ETY)

Eaton Vance Tax-Managed Diversified Equity Income Fund (the Fund) is a diversified, closed-end management investment company. The Fund’s primary investment objective is to provide current income and gains, with a secondary objective of capital appreciation. The Fund invests primarily in a diversified portfolio of common stocks. The Fund will invest at least 80% of its total assets in a combination of dividend paying common stocks, and common stocks the value of which is subject to covered written index call options. It seeks to generate current earnings in part by writing (selling) stock index call options on the S&P 500 Index and investing in dividend-paying common stock. The Fund invests in sectors, such as financials, energy, information technology, industrials, healthcare, consumer staples, telecommunication services, consumer discretionary, materials and utilities.

The Fund’s investment advisor is Eaton Vance Management (EVM). Its sub-advisor is Rampart Investment Management. The Fund may invest in Cash Management Portfolio, an affiliated investment company managed by Boston Management and Research (BMR), a subsidiary of EVM.

Advisors’ Opinion:

  • [By Robert Carlson]

    This recommended fund is Eaton Vance Tax-Managed Diversified Equity Income (ETY). The options that the fund writes give buyers the right to buy the stocks from the fund at fixed prices by a certain date.